powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1154784510
Mallory Lesieur
M.D.
Pulmonary Disease
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
85.0
Quality
60.0
Cost
74.3
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.42%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 200024
Hospital
CCN 201306
Hospital
CCN 201310
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
896
Beneficiaries
—
Total drug cost
$407K
Distinct drugs
20
Brand share
67.1%
Top prescribed drugs
Albuterol Sulfate
164 claims
Fluticasone/Umeclidin/Vilanter
153 claims
Prednisone
108 claims
Fluticasone Propionate
55 claims
Budesonide/Formoterol Fumarate
50 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
239
Unique beneficiaries
—
Total services
307
Distinct HCPCS
8
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 402 Pulmonary Disease providers in MA — below median (cohort median 573).
